192 related articles for article (PubMed ID: 2192711)
41. Prevention of experimental cerebral malaria by anticytokine antibodies. Interleukin 3 and granulocyte macrophage colony-stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation.
Grau GE; Kindler V; Piguet PF; Lambert PH; Vassalli P
J Exp Med; 1988 Oct; 168(4):1499-504. PubMed ID: 3049913
[TBL] [Abstract][Full Text] [Related]
42. Failure to detect interleukin (IL)-3 mRNA or protein in human keratinocytes: antibodies to granulocyte macrophage-colony-stimulating factor or IL-6 (but not IL-3) neutralize "IL-3" bioactivity.
Kondo S; Ciarletta A; Turner KJ; Sauder DN; McKenzie RC
J Invest Dermatol; 1995 Mar; 104(3):335-9. PubMed ID: 7860997
[TBL] [Abstract][Full Text] [Related]
43. Monoclonal antibodies that specifically inhibit GM-CSF- and IL-3-dependent growth of human monocytic leukemia cells.
Taniyama T; Taki S; Nagata M; Yoshizawa K; Hirayama N; Hamuro J; Uchiyama T; Wong G; Rovera G
Growth Factors; 1989; 1(3):263-70. PubMed ID: 2560932
[TBL] [Abstract][Full Text] [Related]
44. Interleukin 1 stimulates T lymphocytes to produce granulocyte-monocyte colony-stimulating factor.
Herrmann F; Oster W; Meuer SC; Lindemann A; Mertelsmann RH
J Clin Invest; 1988 May; 81(5):1415-8. PubMed ID: 2452833
[TBL] [Abstract][Full Text] [Related]
45. Measurement of human granulocyte-macrophage colony-stimulating factor (GM-CSF) by enzyme-linked immunosorbent assay.
Omori F; Okamura S; Hayashi S; Yamaga S; Hirota Y; Niho Y
Biotherapy; 1989; 1(3):161-7. PubMed ID: 2484432
[TBL] [Abstract][Full Text] [Related]
46. Regulation of the genes for interleukin-6 and granulocyte-macrophage colony stimulating factor by different inducers of differentiation in myeloid leukemic cells.
Shabo Y; Lotem J; Sachs L
Leukemia; 1989 Dec; 3(12):859-65. PubMed ID: 2685477
[TBL] [Abstract][Full Text] [Related]
47. Keratinocyte derived T-cell growth factor (KTGF) is identical to granulocyte macrophage colony stimulating factor (GM-CSF).
Kupper TS; Lee F; Coleman D; Chodakewitz J; Flood P; Horowitz M
J Invest Dermatol; 1988 Aug; 91(2):185-8. PubMed ID: 3294304
[TBL] [Abstract][Full Text] [Related]
48. Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony-stimulating factor mRNA and protein. A potential autocrine role for interleukin 1 in epidermis.
Kupper TS; Lee F; Birchall N; Clark S; Dower S
J Clin Invest; 1988 Nov; 82(5):1787-92. PubMed ID: 2460504
[TBL] [Abstract][Full Text] [Related]
49. Rat mesangial cells produce granulocyte-macrophage colony-stimulating factor.
Budde K; Coleman DL; Lacy J; Sterzel RB
Am J Physiol; 1989 Dec; 257(6 Pt 2):F1065-78. PubMed ID: 2690641
[TBL] [Abstract][Full Text] [Related]
50. The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils.
Tai PC; Spry CJ
Clin Exp Immunol; 1990 Jun; 80(3):426-34. PubMed ID: 2197048
[TBL] [Abstract][Full Text] [Related]
51. Histamine-producing cell-stimulating activity. A biological activity shared by interleukin 3 and granulocyte-macrophage colony-stimulating factor.
Dy M; Schneider E; Gastinel LN; Auffray C; Mermod JJ; Hamburger J
Eur J Immunol; 1987 Sep; 17(9):1243-8. PubMed ID: 2888659
[TBL] [Abstract][Full Text] [Related]
52. Post-transcriptional regulation of granulocyte-macrophage colony-stimulating factor synthesis in murine T cells.
Bickel M; Cohen RB; Pluznik DH
J Immunol; 1990 Aug; 145(3):840-5. PubMed ID: 2197329
[TBL] [Abstract][Full Text] [Related]
53. Mechanisms of tumor-induced neutrophilia: constitutive production of colony-stimulating factors and their synergistic actions.
Lee MY; Kaushansky K; Judkins SA; Lottsfeldt JL; Waheed A; Shadduck RK
Blood; 1989 Jul; 74(1):115-22. PubMed ID: 2473793
[TBL] [Abstract][Full Text] [Related]
54. Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients.
Limaye AP; Abrams JS; Silver JE; Ottesen EA; Nutman TB
J Exp Med; 1990 Jul; 172(1):399-402. PubMed ID: 2193099
[TBL] [Abstract][Full Text] [Related]
55. Production of granulocyte-macrophage colony-stimulating factor but not IL-3 by normal and neoplastic human B lymphocytes.
Zupo S; Perussia B; Baldi L; Corcione A; Dono M; Ferrarini M; Pistoia V
J Immunol; 1992 Mar; 148(5):1423-30. PubMed ID: 1538127
[TBL] [Abstract][Full Text] [Related]
56. Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin-5.
Sonoda Y; Arai N; Ogawa M
Leukemia; 1989 Jan; 3(1):14-8. PubMed ID: 2642572
[TBL] [Abstract][Full Text] [Related]
57. Tumor necrosis factor-alpha and tumor necrosis factor-beta (lymphotoxin) stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo.
Kaushansky K; Broudy VC; Harlan JM; Adamson JW
J Immunol; 1988 Nov; 141(10):3410-5. PubMed ID: 2460533
[TBL] [Abstract][Full Text] [Related]
58. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
[TBL] [Abstract][Full Text] [Related]
59. In vitro differentiation and proliferation of human hematopoietic progenitors: the effects of interleukins 1 and 6 are indirectly mediated by production of granulocyte-macrophage colony-stimulating factor and interleukin 3.
Migliaccio G; Migliaccio AR; Adamson JW
Exp Hematol; 1991 Jan; 19(1):3-10. PubMed ID: 1989893
[TBL] [Abstract][Full Text] [Related]
60. Autocrine regulation of macrophage proliferation by tumor necrosis factor-alpha.
Branch DR; Guilbert LJ
Exp Hematol; 1996 May; 24(6):675-81. PubMed ID: 8635522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
